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Protein cross-linking by chlorinated polyamines and
transglutamylation stabilizes neutrophil
extracellular traps
Krisztián Csomós1,6, Endre Kristóf1, Bernadett Jakob1, István Csomós2, György Kovács3,7, Omri Rotem1, Judit Hodrea1,8,
Zsuzsa Bagoly4,5, Laszlo Muszbek4,5, Zoltán Balajthy1, Éva Csősz1 and László Fésüs*,1
Neutrophil extracellular trap (NET) ejected from activated dying neutrophils is a highly ordered structure of DNA and selected
proteins capable to eliminate pathogenic microorganisms. Biochemical determinants of the non-randomly formed stable NETs
have not been revealed so far. Studying the formation of human NETs we have observed that polyamines were incorporated into
the NET. Inhibition of myeloperoxidase, which is essential for NET formation and can generate reactive chlorinated polyamines
through hypochlorous acid, decreased polyamine incorporation. Addition of exogenous primary amines that similarly to
polyamines inhibit reactions catalyzed by the protein cross-linker transglutaminases (TGases) has similar effect. Proteomic
analysis of the highly reproducible pattern of NET components revealed cross-linking of NET proteins through chlorinated
polyamines and ε(γ-glutamyl)lysine as well as bis-γ-glutamyl polyamine bonds catalyzed by the TGases detected in neutrophils.
Competitive inhibition of protein cross-linking by monoamines disturbed the cross-linking pattern of NET proteins, which resulted
in the loss of the ordered structure of the NETand significantly reduced capacity to trap bacteria. Our findings provide explanation
of how NETs are formed in a reproducible and ordered manner to efficiently neutralize microorganisms at the first defense line of
the innate immune system.
Cell Death and Disease (2016) 7, e2332; doi:10.1038/cddis.2016.200; published online 11 August 2016
Neutrophils act as the first line of defense in the immune
response against microbes and parasites. In addition to
phagocytosis, generation of reactive oxygen species (ROS)
and antimicrobial macromolecules, neutrophil extracellular
trap (NET) was discovered more than a decade ago as an
additional neutrophil task.1 Upon various inflammatory stimuli,
neutrophils become activated and undergo a specific form of
cell death (termed NETosis) in which they eject preprocessed
DNA content in the form of a web-like structure thereby
having the ability to trap, neutralize and eradicate invading
pathogens. The molecular mechanism of NETosis involves
stimulation of neutrophil surface receptors (Toll-like receptors
(TLRs), Fc and/or complement) leading to elevation of
intracellular calcium, activation of protein kinase C and
formation of ROS.2 Subsequent downstream events lead to
changes in the composition of the cytoplasm, in which
disintegration of the nuclear and granular membranes
allows mixing of their contents. Unwinding of the chromatin
appears to be dependent on histone deamination catalyzed
by peptidylarginine deiminase 4 (PAD4), eventually culminat-
ing in extrusion of a characteristic NET structure into the
extracellular space.
The NET itself is a complex and highly organized extra-
cellular structure composed of a DNA backbone of interwoven
filaments with a diameter of 15–17 nm containing stacked
nucleosomes.3 The strands aggregate into larger threads with
a diameter of 50 nm and can further form much larger three-
dimensional web-like structures, measuring hundreds of
nanometers in length and width. In addition to the function of
the NETas a physical barrier, the DNA backbone is embedded
with a number of peptides, proteases (neutrophil elastase
(NE), myeloperoxidase (MPO) and bactericidal permeability
increasing protein) and histones (H1, H2A, H2B, H3 and H4)
contributing to the direct microbicidal effect of the NET.
Molecular determinants of the reproducibly formed, well-
ordered NETarchitecture have not been revealed yet.
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Examination of the three-dimensional structure, the non-
random orientation of its fibers and the overall stability of the
NET has directed our attention to specific covalent protein–
protein cross-link formation, which may determine these
features. Primary amines (including polyamines) were found
to be chemically incorporated into proteins through mono- and
dichloramine intermediates generated in the presence of
hypochlorous acid (HOCl).4 Neutrophil NADPH oxidase and
MPOgenerate a highly oxidative state in activated neutrophils,
which is necessary for incorporation of chlorinated amines.5,6
Indeed, more recently, intracellular MPO activity was impli-
cated in functional NET formation at a cell-autonomous but so
far uncharacterized way.7 Covalent bonds can be generated
enzymatically by transglutaminases (TGases) that are
Ca2-dependent enzymes and able to form protease resistant
ϵ-(γ-glutamyl)lysine cross-links between the γ-carboxamido
group of glutamine residues and the ϵ-amino group of lysine
residues in polypeptides. Members of the TGase family have
been implicated in the organization and stabilization of highly
organized protein assembles, such as the fibrin clot, the
extracellular matrix and the cornified envelope in the skin.8–21
In the presence of naturally occurring di- and polyamines
(putrescine (PUT), spermidine (SPD) and spermine (SPM)),
TGases also catalyze amine incorporation into spatially
accessible glutamines in substrate proteins resulting in mono
(γ-glutamyl)- or bis(γ-glutamyl)-PUT, -SPD or-SPM.22–24 Here
we show that cross-link formation between NET-specific
proteins by chlorinated polyamines and TGase-catalyzed
reaction in activated neutrophils are necessary to form
functional NETs.
Results
Covalent incorporation of endogenous polyamines into
neutrophil proteins during NETosis. In order to investigate
whether endogenous polyamines may have a role in the
formation of NET, we first attempted to detect SPM and SPD
covalently bound to cellular proteins in resting and activated
NET-forming human neutrophils by confocal microscopy. In
resting neutrophils, covalently bound SPM and SPD were
hardly detectable. In contrast, activation of neutrophils either
with the protein kinase C activator, phorbol-12-myristate
13-acetate (PMA), or with the live pathogen Staphylococcus
aureus revealed a strong dotted pattern in polyamine
staining. The size of SPM and SPD-rich speckles was in
the range of 1–2 μm and the dots were localized in the
area occupied by the decondensed chromatin (Figure 1a).
Interestingly, polyamine speckles along with the NET DNA
filaments were also detected suggesting that endogenous
polyamines get incorporated into the protein fraction of the
NET too (Figure 1b).
Using ELISA, we detected an increase in the level of
covalently bound polyamines (SPM and SPD) to cellular
protein of PMA-stimulated neutrophils. This increase could be
reverted in the presence of aminobenzoic acid hydrazide
(ABAH), a MPO inhibitor. Covalent incorporation of exo-
genously administered SPM was also observed occurring in a
partially MPO-dependent manner as indicated by its ABAH
inhibition (Figure 1c). Endogenous polyamines as well as
added SPM could also be detected in proteins isolated from
the NET (Figure 1d). As MPO function is essential for the
entire NET formation, it is not possible to utilize ABAH to
investigate the role of MPO in polyamine incorporation
into NET proteins. Therefore, we tested the effect of the
5-(biotinamido)-pentylamine (BPNH2) as a potential competi-
tive monoamine inhibitor of polyamine incorporation.25
BPNH2 efficiently reduced the level of both endogenous and
extraneous SPM in NET proteins (Figure 1d).
Next, we tested polyamine conjugation to cellular and NET
proteins in the presence of different monoamine derivatives
with immunostaining. Besides BPNH2, we used pentylamine
(PNH2) as an unmodified monoamine and N-methylpentyla-
mine (MPNH2) as a negative control. As Figure 1e shows both
monoamines with free terminal amino groups (BPNH2 and
PNH2) interfered with endogenous polyamine incorporation
into cellular proteins, as a reduced number of polyamine
containing dots was detectable inside the NET-forming
neutrophils (Figure 1e, panels I–III). MPNH2 that lacks a
terminal amino group did not influence endogenous polyamine
incorporation levels (Figure 1e, panel IV), although it had
similar inhibitory effect on ROS generation as PNH2
(Supplementary Figure 1). Furthermore, although overloading
the neutrophils with SPM also caused reduced ROS produc-
tion (Supplementary Figure 1),26,27 it resulted in a significant
increase in the number of detectable covalently bound
polyamine containing dots (Figure 1e, panel V). Polyamine
content of NET-specific proteins was also reduced in the
Figure 1 Endogenous and exogenous polyamines are incorporated into cellular and NET-specific proteins during NET formation. (a) Representative images of SPD and SPM
distribution in resting (I), 4 h PMA-(II) and S. aureus (III) activated human neutrophils. Left panels show polyamines (red) and DNA (green); right panels show polyamine staining
alone. Experiment was repeated at least six times with neutrophils from independent healthy donors, with similar results. Original magnification was × 60, scale bar represents
5 μm. (b) Representative images of SPD and SPM content of NET. Neutrophils were treated with PMA (I–II) or S. aureus (III) and stained as in a. Left panels show polyamines
(red) and DNA (green); right panel shows polyamines alone. Experiment was repeated at least six times with neutrophils from independent healthy donors, with similar results.
Original magnifications were × 40 (I) or × 60 (II and III) and scale bars represent 20 μm (I) or 5 μm (II and III). (c) Detection of polyamine incorporation into cellular proteins with
ELISA. Resting and PMA-activated neutrophils were cultured alone or in the presence of SPM, ABAH (MPO inhibitor) or SPM and ABAH and then covalently conjugated
polyamines were quantified from cell lysate. (d) Detection of polyamine incorporation into NET-specific proteins with ELISA. NET formation was induced alone or in the presence
of SPM, BPNH2 or SPM and BPNH2 and then covalently conjugated polyamines to proteins were quantified. ELISA experiments for cellular and NET proteins were performed on
neutrophils isolated from five independent healthy donors in duplicates. Data are presented as mean± S.E.M. Differences on treatments were tested for significance with paired
Student’s t-test. *Po0.05; **Po0.01; ***Po0.001. (e) Representative images of SPD/SPM distribution in neutrophils activated for 4 h with PMA alone (I), or in the presence of
BPNH2 (II), PNH2 (III), MPNH2 (IV) or SPM (V). Upper panels show polyamines (red) and DNA (green); lower panels show polyamine staining alone. (f) Representative images of
SPD/SPM content of the NET from neutrophils treated and stained as in Figure 2a. Upper panels show polyamines (red) and DNA (green); lower panels show polyamine
staining alone. Experiment was repeated at least four times with neutrophils from independent healthy donors, with similar results. Original magnification was × 60, scale bar
represents 10 μm
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presence of monoamineswith a reactive terminal amino group
(BPNH2 and PNH2), whereas MPNH2 did not have any effect
(Figure 1f, panels I–V). In addition, exogenous SPMwas again
notably incorporated into NET-specific proteins along the
strands of the NET structure (Figure 1f, panel V).
These data indicate that upon NET formation endogenous
polyamines are covalently incorporated into cellular and NET-
specific proteins that process depends on MPO activity. Also,
the level of the protein-bound polyamines can be increased
by the administration of exogenous SPM and reduced by
monoamine treatment.
Monoamines mimic endogenous polyamine incorpora-
tion in NETosing neutrophils. To characterize monoamine
incorporation into cellular and NET-specific proteins, we
induced NET formation in the presence of BPNH2. Proteins
covalently labeled with BPNH2 were detected in PMA-activa-
ted neutrophils, whereas cellular proteins in resting cells
remained unconjugated (Figure 2a, panels II and I, respec-
tively). Proteins localized in the NET structure were also
labeled with BPNH2 (Figure 2a, panel III). Based on the
same pattern of monoamine incorporation (BPNH2) and of
endogenous polyamines detected by immunohistochemistry,
we assumed that monoamine incorporation can be used as a
tool to further characterize amine incorporation.
As a next step, protein extracts from neutrophils were
separated in sodium dodecyl sulfate (SDS)–polyacrylamide
gels and proteins into which BPNH2 had been incorporated
were visualized by western blot using HRP-conjugated
streptavidin. As Figure 2b shows, upon PMA stimulation
several cellular proteins labeled with BPNH2 were detectable
at various molecular weights. A stronger modification was
observed when neutrophils were activated with pathogen
stimulation (Figure 2b). BPNH2 incorporation continuously
increased in time during neutrophil activation (Figure 2c).
Treatment with a polyamine derivative, monodansylcadaver-
ine (MDC) resulted in a notable reduction in BPNH2 incor-
poration in cellular and as well as NET proteins suggesting
competition between monoamines and polyamines for target
proteins (Figure 2d).
Proteomic analysis of the NET reveals polyamine-
mediated protein cross-links by chlorinated polyamines
and TGase reaction. Next, we analyzed protein fraction of
NET with SDS-polyacrilamide gel electrophoresis (PAGE)
and identified a highly reproducible pattern in the protein
composition of NET (Figure 3a). By mass spectrometry, we
could identify 16 NET proteins 14 of which (azurocidin AZU1,
NE, protein S100-A8, protein S100-A9, lactotrasferrin, MPO,
transketolase, catalase, alpha-enolase, cathepsin G, lyso-
zyme C, histone H2A, histone H2B, histone H3 and histone
H4) have already been described,3 whereas 2 (leukocyte
elastase inhibitor 1 and protein S100-A6) have not been
reported as NET components so far. Gel image analysis of
untreated, BPNH2 and SPM-treated NET proteins revealed
that although the pattern of protein composition was not
different, alterations in band intensities upon BPNH2 and
SPM treatment occurred (Figure 3a). Subsequent LC-MS/MS
based identification of NET proteins (Supplementary Table 1)
showed that while some proteins were identified in bands
corresponding to their theoretical molecular weights, many
migrated to different positions (Figure 3b) indicating extensive
protein processing.
The mass spectrometry data obtained from identified
proteins were examined with the software, StavroX28 for
the possible presence of bis-ε-lysyl polyamine and
ε-lysyl-S-methionyl polyamine cross-links, which can be gen-
erated by chlorinated polyamines4 as well as bis-γ-glutamyl
polyamine and ε(γ-glutamyl)lysine cross-links formed by TGase
reaction29,30 (Figures 4a and b). The four types of cross-links
formed between specific residues of the NET proteins could be
found (Figures 4a and b) as detailed in Supplementary data set
(http://ngsdebftp.med.unideb.hu/proteomics/).
Mass spectrometry data were examined with the software,
StavroX, to identify cross-links formed at specific side chains
between the recognized proteins.31 We could find bis-ε-lysyl
polyamine and ε-lysyl-S-methionyl polyamine cross-links
formed by chlorinated polyamine incorporation and bis-γ-
glutamyl polyamine as well as ε(γ-glutamyl)lysine cross-links
typically catalyzed by a TGase type reaction (Figures 4a
and b,Supplementary Table 1). The detected number of cross-
links was similar or somewhat lower in BPNH2-treated
samples (except for PUT derivatives, which were increased)
and SPM-treated samples yielded an increased number of this
type of cross-links. A similar tendency was observed regard-
ing the number of TGase formed bis-γ-glutamyl polyamine and
ε(γ-glutamyl)lysine cross-links (Figure 4b). Representation of
the pattern of detected cross-links revealed a polyamine and
ε(γ-glutamyl)lysine-mediated covalent network formed among
NET proteins and also reveals changes in the position of
cross-links upon BNPH2 and SPM treatment (Figure 4c,
Supplementary Table 2) when different cross-links are formed
at different positions resulting in alterations of the network of
cross-linked NET proteins.
Potential role of TGase 1 in cross-link formation in
NETosis. Based on the proteomic data, we propose that
besides chlorinated polyamine-mediated mechanisms enzy-
matic polyamination and protein cross-linking by TGase also
occur in activated neutrophils. Therefore, we tested if the
amine incorporation depends on the presence of Ca2+ as a
hallmark of TGase-mediated reaction. As NET formation in
itself is Ca2+ dependent, first we initiated NETosis with PMA
in the presence of Ca2+. After 2 h, calcium ion was scavenged
from the culture medium with ethylenediaminetetraacetic acid
(EDTA) for 30 min, then BPNH2 was given to NETosing
cells for 3 h. As a result, significant decrease in the amount of
monoamine-conjugated proteins was observed in samples
lacking Ca2+ in the last 3 h of NETosis (Figure 5a, lines 4 and
6). To further investigate possible TGase catalyzed amine
incorporation, we modified a radioactive filter paper-based
TGase activity assay32 to demonstrate PUT conjugation as
alternative exogenous polyamine incorporation. After indu-
cing NETosis detection of conjugated [3H]putrescine to
proteins in neutrophil lysates showed a significant increase
(Figure 5b). Incorporation was diminished in the presence of
MDC. These observations suggest enzymatically mediated
conjugation of mono- and polyamines by a TGase supple-
menting the chlorination driven amine incorporation.
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Next, in a search for the potential presence of TGases,
the expression of TG1-6 and Factor XIII-A expression levels
were measured. From the seven investigated variants, TG1
and Factor XIII-A were found to be transcribed at significant
levels (Figure 5c), whereas the ubiquitous TG2 was not
detectable at mRNA (Figure 5c) or at protein level (data not
shown). Interestingly, we managed to detect TG1 by immuno-
blotting and immunohistochemistry (Figures 5d and e). TG1
must be activated by proteases;31 the cleaved active form
was detected similarly as in TG1-transfected cells. More-
over, specific TG1 activity could be measured in neutro-
phil lysate utilizing a TG1-specific glutamine substrate
(Figure 5f) indicating that it can potentially contribute to
polyamine incorporation and protein cross-linking during
NETosis.
To demonstrate FXIII-A expression, we performed immuno-
histochemistry analysis on neutrophils isolated from healthy
individuals as well as a FXIII-A-deficient patient. In neutrophils
from a healthy donor, FXIII-A could be visualized at a
lower level than in monocytes, whereas in the neutrophils or
Figure 2 Exogenous monoamines mimic endogenous polyamine incorporation occurring in NETosing neutrophils. (a) Representative images of BPNH2 incorporation into
neutrophil intracellular and NET proteins upon 4-h activation with PMA. Neutrophils from healthy donors were preincubated with BPNH2 for 1 h and then stimulated with PMA or
left unstimulated for 4 h (control). (I) Shows BPNH2 incorporation in resting neutrophils; (II) shows BPNH2 incorporation in activated neutrophils; and (III) shows BPNH2
incorporation into NET proteins. Upper panels show BPNH2 (light blue) and DNA (red); lower panels show BPNH2 staining alone. The experiment was repeated at least three
times with neutrophils from independent healthy donors, with similar results. The original magnification was × 60, the scale bar represents 10 μm. (b) Detection of exogenous
monoamine (BPNH2) incorporation into cellular proteins in activated neutrophils by western blot. Neutrophils from a healthy donor were preincubated with BPNH2 and then
stimulated either with PMA or S. aureus or left unstimulated for 4 h (control). Levels of BPNH2 incorporation into cellular proteins were determined from cell lysate with western
blot. (c) Time-dependent incorporation of BPNH2 into neutrophil cellular proteins upon activation. Neutrophils from a healthy donor were preincubated with BPNH2 and then
stimulated with PMA for 0–5 h. BPNH2 incorporation levels were detected as in Figure 2b. (d) Effect of MDC on BPNH2 incorporation into cellular and NET proteins. Neutrophils
were preincubated with BPNH2 or BPNH2 and MDC followed by PMA stimulation for 4 h or left unstimulated (control). Cellular and NET proteins were isolated and BPNH2
incorporation levels were detected as in Figure 2b
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monocytes of the FXIII-A-deficient patient, we failed to detect
any specific staining in neutrophils or monocytes
(Supplementary Figure 2A). Staining pattern of FXIII-A in
neutrophils from healthy donors showed granular localization
suggesting that FXIII-A content of neutrophils may derive from
phagocytosed platelets. Although a traceable amount of FXIII-
A could be detected in neutrophils of healthy individuals, the
administration of NC9, a specific FXIII-A inhibitor33 did not
affect the BPNH2 incorporation into cellular and NET proteins
(data not shown). In line with this, isolated and PMA-activated
neutrophils of a FXIII-A-deficient patient were able to form a
functional NET structure and the level of BPNH2 incorporation
was comparable to controls (Supplementary Figure 2B)
suggesting that FXIII-A in human neutrophils does not
contribute to NET formation.
Mono- and polyamine treatment disrupt NET structure.
In order to clarify the role of polyamine incorporation and
protein cross-linking in NET formation and stabilization, we
analyzed multiple parameters of normal and competitive
inhibitor treated NETs. NET structure was dissected by
Z-stacking in 0.5 μm slices to a 50 μm range above the layer
of the attached cells. Monoamines with a reactive terminal
amino group (PNH2, BPNH2 and MDC) significantly altered
NET structure (Figure 6a). Differences especially concerned
the organized orientation of NET filaments and density of the
25
Figure 3 Proteomic analysis of the NET confirms protein cross-linking. (a) SDS-PAGE of untreated (Ctrl), BPNH2 and SPM treated NET proteins. In all, 20 μg of protein from
each sample was subjected to SDS-PAGE on a 12% acrilamide gel for 1.5 h at 30 mA constant current and stained with PageBlue Protein Staining Solution. The detected bands
and the band numbers assigned by QuantiyOne (Bio-Rad) band analysis software are marked with red. D1, D2 and D3 indicate three independent healthy donors involved in the
analysis. (b) List of proteins identified by LC-MS/MS based mass spectrometry analysis in each band. Italics indicate the presence of proteins at molecular weights different from
the expected. The Uniprot gene name of identified proteins is presented in the table. The estimated MW values are also indicated. For protein identification details, see
Supplementary Table 1
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DNA strands, in addition to complete lack or diminished
frequency of the thin DNA filaments (o0.5 μm in width) upon
monoamine treatment. SPM excess also disrupted NET
structure and resulted in fewer strands of a thicker composi-
tion (Figure 6a, panel VI). MPNH2 had no significant effect on
the structure (Figure 6a, panel II).
Computational analysis of the confocal microscopic images
obtained by Z-stacking allowed us to objectively determine
characteristic parameters of the NET structure. We identified a
significant decrease in the average number of junctions per unit
strand length upon monoamine and SPM treatment, whereas
therewas no detectable difference in the average lengths of the
strands. In the average strand width, we observed increased
values upon such treatments, although none of these were
significant according to Welch's t-test (Figure 6b, panels I–II).
Regarding the strand orientation, a significantly larger portion
was directed in an unordered manner suggesting disorganiza-
tion of the whole structure in response to the monoamine or
SPM treatment (Figure 6b, panels III–IV).
Disruption of NET structure compromises bacterial
trapping. To investigate functional consequences of disrupt-
ing the normal NET structure, we first visualized immobilized
FITC-labeled S. aureus associated with NET. The organized
NET structure of control neutrophils was able to capture large
number of bacteria, whereas the amount of trapped bacteria
was significantly reduced if the neutrophils were treated
either with BPNH2 or MDC (Figure 7a). The trapping capacity
of NETs derived from differently treated neutrophils was
determined by bacterial trapping assay. Consistently with
microscopic observations, neutrophils forming NET in the
presence of either BPNH2 or MDC were able to immobilize
significantly lower amount of bacteria compared with control
cells (Figure 7b). Thus, we concluded that endogenous
polyamine incorporation and protein–protein cross-links
associated with the normal NET formation is essential for
neutrophils to trap bacteria efficiently.
Discussion
The observation of the reproducibly generated characteristic
NET architecture with restricted protein composition34,35
fostered us to investigate possible biochemical events that
regulate NET formation. Polyamines and nuclear aggregates
of polyamines are present in NET and have already been
proposed to have possible role in stabilizing NET structure by
Figure 4 Analysis of protein cross-links between the identified NET proteins. (a) Selected examples for cross-links formed between the identified NET proteins.
(b) The number of cross-links identified by the Stavrox software. The values apply to the number of cross-links confirmed by three independent Stavrox analyzes.
(c) Representation of the network of cross-linked NET proteins obtained from donor 3. Blue arrows indicate NET protein cross-links within untreated samples; red arrows
show cross-links among NET proteins upon BPNH2 treatment, whereas the orange arrows represent the protein cross-links formed upon SPM treatment. Curved arrows
indicate cross-links formed between copies of the same protein. In case of the presented cross-linked proteins, the Uniprot gene names are indicated. For raw data, see
Supplementary Table 2
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Figure 5 Detectable expression and activity of TG1 in NETosing neutrophils. (a) Calcium dependence of BPNH2 incorporation into cellular proteins. NETosis was initiated in
neutrophils with PMA for 2 h in the presence of Ca2+, and then cells were either treated with EDTA for 30 min or left untreated. BPNH2 was given to the pretreated cells for
additional 2 h and finally its incorporation levels were detected similar to the previous experiments. (b) Detection of exogenous polyamine (PUT) incorporation into cellular
proteins in activated neutrophils by in situ radioactive filter paper TGase activity assay. Neutrophils from a healthy donors were preincubated with [3H]putrescine and then
stimulated either with PMA or PMA and MDC or left unstimulated for 4 h (control). Level of [3H]putrescine incorporation into cellular proteins was determined from cell lysate. [3H]
putrescine incorporation in PMA-activated neutrophils was significantly increased and slightly diminished in the presence of MDC. Data are represented as mean± S.E.M. based
on two independent healthy donors with three parallels in each experiment. (Paired Student’s t-test, **Po0.01). (c) Detection of TG1, TG2, TG3, TG4, TG5, TG6 and Factor XIII
expression in neutrophils by real-time qPCR. Neutrophils were isolated from two independent healthy donors and relative mRNA levels of TGases were determined using
cyclophillin A transcript as reference. (d) Detection of TG1 at the protein level in neutrophils. Neutrophils and other human myeloid cells were lysed and TG1 protein levels were
detected by western blot. HaCaTand TG1 overexpressing HEK cells were used as positive controls. The same bands, corresponding to the full length and the protease cleaved
short forms of TG1 (ref 29), could be observed in the neutrophil cell lysate as in the HEK cells overexpressing TG1. GAPDH level was detected as loading control. (e)
Representative images of imunofluorescent staining of TG1 in human neutrophils. Resting (I and II) and PMA-activated (III and IV) neutrophils were stained with an anti-TG1
rabbit polyclonal antibody and Alexa Fluor-647-conjugated goat anti-rabbit secondary antibody (red) and SYTO 83 orange fluorescent nucleic acid stain to visualize DNA (green).
Images II and VI show the negative control for TG1 staining, where the primary antibody was omitted. The experiment was repeated at least four times with neutrophils from
independent healthy donors, with similar results. The original magnification was × 60, the scale bar represents 10 μm. (f) Detection of specific TG1 activity in neutrophil cell lysate.
TG1 activity was detected by ELISA in resting and PMA-activated neutrophils and HaCaT (positive control) cell lysates alone or in the presence of the non-specific irreversible
TGase inhibitor IAA or the specific irreversible TG2 and FXIII-A inhibitor (ZDON, not tested previously for TG1 inhibition) using a TG1-specific substrate peptide
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interacting with its DNA backbone.36 In this study, we have
demonstrated that covalent cross-linking of the protein content
of the NET is an integral and stabilizing constituent of
functional NET formation. Owing to their multiple reactive
amino groups, it seemed conceivable that polyamines could
act as linker agents resulting in intermolecular protein–protein
cross-link formation. Indeed, utilizing specific antibodies to
polyamines we could demonstrate the presence of covalently
linked polyamines in the protein content of the NET by
immunohistochemistry and ELISA. Stimulation of neutrophil
oxygen metabolism with PMA in the presence of primary
amines, including polyamines, resulted in oxidative amine
incorporation into proteins.4,37 The process involves MPO-
catalyzed oxidation of chloride to HOCl in the presence of
hydrogen peroxide, followed by chlorination of exogenously
added amines as well as endogenous cellular amines to yield
nitrogen–chlorine derivatives, which can modify proteins in
neutrophils.4,37 Here, we have shown that chlorinated poly-
amines get covalently incorporated into NET proteins by a
process that we found not affected by the inhibitory effect of
mono- and polyamines on ROS generation.26,27 Furthermore,
polyamines chlorinated at both primary amino groups can form
cross-links between NET proteins contributing to NET stability.
This may also explain why MPO is required for proper
NET formation.7 Based on our findings, we propose that
during NET formation MPO, beyond facilitating chromatin
de-condensation in conjunction to elastase in the nucleus,38 is
preferentially located at DNA strands to form HOCl that
subsequently generates chlorinated polyamines with cross-
linker potential. Chlorinated polyamines then promote cova-
lent linkage among specifically assembled proteins destined
to be selectively released with DNA strands of the NET.
Polyamines are natural substrates of TGases and TGase-
mediated incorporation of polyamines into proteins occurs in
cells and tissues modifying, for example, cornification in the
skin, lens crystallines, functions of actin, tubulin, RhoA,
histones and heat shock proteins.22,29,30,39–42 Cornification
and crystallin modifications are particularly relevant to this
study as in both processes TGase-mediated formation of bis
(γ-glutamyl)polyamine cross-links between proteins by
TGase 1 and 2, respectively, was observed29,30,40 in parallel
to protein cross-linking through ε(γ-glutamyl)lysine bonds. NET
protein fractions contain both bis(γ-glutamyl)polyamine and
ε(γ-glutamyl)lysine bonds suggesting that TGase-mediated
cross-linking contributes to selective enrichment of specific
proteins in the NETand its stabilization. In line with these data,
we observed Ca2+-dependent TGase activity using PUT and
BNPH2 during NETosis. Thus, besides Ca
2+-independent,
Welch's t-test 
P values  
*BPNH2 *MDC
I. Average Length of Strands 0.84 0.93 
II. Average Width of Strands 0.079 0.39 
III. Number of Junctions per Unit Strand Length 0.016 0.0034 
IV. Portion of Strands Fitting the Principal Orientation 0.000011 0.000002 
I
III                           IV    
V                VI 
II
Figure 6 Monoamines and exogenously administered SPM disrupt normal NET structure. (a) Representative images of NET structures generated with PMA alone (I), or in
the presence of MPNH2 (II), PNH2 (III), MDC (IV), BPNH2 (V) or SPM (VI) for 4 h. DNAwas stained with SytoxOrange (red). The experiment was repeated at least four times with
neutrophils from independent healthy donors, with similar results. The original magnification was × 60, the scale bar represents 10 μm. (b) Quantitative evaluation of different
parameters of the NET. The average length (I) width (II) of the NET strands, number of junctions per unit strand length (III) and the orientation of the DNA filament (IV) were
quantified from control, BPNH2 and MDC treated NETs derived from four independent donors. At least 10 independent fields of view from each sample (donor and treatment)
were used for the calculation. Data are presented with box and whisker plots and Welch's t-test was used for testing the equality of the means of any two samples. P-values are
summarized in chart
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chlorination-mediated amine incorporation, TGase activity
contributes to cross-link formation stabilizing NET structure.
We found that FXIII-A and TGase 1 are present in
neutrophils. However, neutrophils isolated from a FXIII-A-
deficient patient could incorporate primary amines into
proteins during NETosis to a similar degree as controls
making it unlikely that this FXIII-A has a major role in cross-
link formation. TGase 1 has a pivotal role in the cornification
process 43 cross-linking a set of proteins expressed during
terminal differentiation of keratinocytes. According to our
presented data, TG1 is also expressed in circulating neu-
trophils where it is cleaved and activated by a so far not
identified protease. TG1 is one of the least restricted TGases
in glutamine substrate specificity and we suggest it can
serve, in addition to chlorinated polyamines, as a cross-linker
enzyme assembling and stabilizing a broad set of NET
proteins.
Surprisingly, the SDS-polyacrylamide electrophoretic
separation pattern of the NET proteins prepared from
stimulated neutrophils of different individuals was highly
reproducible but the composition of the protein bands was
heterogenic containing polypeptides with molecular weights
different from what was expected suggesting their extensive
posttranslational processing during NET formation involving
both cross-link formation and proteolysis. The analysis of
cross-links formed by chlorinated polyamines and TGase-
dependent reactions between the proteins (Figure 4) indicates
the formation of an extensive and specific cross-linking pattern
keeping these proteins or their modified and processed forms
together. The highly standard electrophoretic band pattern of
the NETrevealed by consecutive separations and the fact that
the SPM and BNPH2 treatments did not alter it significantly
but rather resulted in minor changes in protein composition
indicates a robustness of the NET-forming biochemical
systems. The nature of the obtained data and the cross-link
analysis software cannot provide reliable quantitative informa-
tion regarding the precise number of cross-links formed;28 in
the experimental setup used only an approximation can be
done. The variety of the position of the amino-acid residues
participating in cross-link formation can be the result of
extensive three-dimensional structure modifications caused
by protease action (especially NE and cathepsin G) and
citrullination.44 Converting the positively charged arginine to
uncharged citrulline can destroy the functional structure of the
proteins or can cause conformational changes leading to
surface accessibility of otherwise buried amino acids permit-
ting cleavage or cross-link formation.45 Limited proteolysis in a
very similar manner as citrullination can lead to conformational
changes46 making residues available for citrullination or
cross-link formation. It is not known which of these processes
happen first and in which extent they participate in NET
formation. Much more accurate mass spectrometry analyzes
are needed to get in-depth qualitative and quantitative
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Figure 7 Disruption of NET structure by interfering endogenous polyamine incorporation by monoamines compromises bacterial trapping capacity of the NET. (a)
Representative images of trapped S. aureus in NETs generated with PMA (I) or in the presence of MDC (II) or BPNH2 (III). Left panels show NET (red) and FITC-labeled trapped
S. aureus (green); right panel shows S. aureus alone. Experiment was repeated three times with neutrophils from independent healthy donors, with similar results. Original
magnifications were × 40 and scale bars represent 10 μm. (b) Quantification of the trapping capacity of the NET by bacterial trapping assay. Neutrophils were plated and activated
in an ELISA plate for 3 h with PMA (control), PMA and MDC (100 and 250 μM) or PMA and BPNH2 (0.5 and 2 mM). Phagocytosis was blocked by cytochalasin D then FITC-
labeled S. aureus was given to the cells in 1 : 100 neutrophil:bacterium ratio for additional 1 h. Unbound bacteria were washed away and fluorescence (proportional to the amount
of the trapped bacteria) was determined by an ELISA reader. Experiment was repeated three times with neutrophils from independent healthy donors (n= 3) with six technical
parallels. Data represent mean±S.D. ***Po0.001, **Po0.01 as compared with controls by Student’s t-test
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information on the effect of citrullination, proteolysis and cross-
link formation on the NET structure.
To investigate NET functionality when polyamine and
TGase-dependent cross-linking is prevented, we used alipha-
tic monoamines, including BPNH2, which can interfere with
both non-enzymatic and TGase-dependent cross-link forma-
tion. Monoamines get incorporated into cell and NET-specific
proteins during NETosis as demonstrated in situ with
immunohistochemistry, in cell lysate and isolated NET protein
preparations. We observed a different labeling pattern when
we compared cellular proteins with NET-specific proteins
(Figure 3) indicating that protein mono- and polyamination
occur at a biochemically regulated manner selectively target-
ing a fraction of the protein in NETosing neutrophils. We
presumed that endogenous polyamines and monoamines
may compete for specific amine binding sites on the surface of
proteins. Indeed, parallel with the exogenous monoamine
incorporation, we observed significant reduction in the level of
the endogenous polyamine incorporation. Hence, mono-
amines are potent inhibitors to reduce the level of endogenous
polyamine incorporation as well as to modify the polyamine
and ε(γ-glutamyl)lysine cross-linking processes (Figure 4).
Using monoamines as cross-linking inhibitors, we observed
significantly altered NET structure. Furthermore, overloading
NETosing neutrophils with exogenous SPM also lead to
disturbed NET architecture. Computational analysis revealed
that changes in NET structure particularly affected width
and the orientation of the NET filaments and the frequencies of
the junctions per unit strand (Figure 6). The covalently
incorporated polyamines into the protein globules of the
NET may also serve with their internal positive charge as
anchor points for the DNA strands and disturbing the regu-
lated pattern of polyamine linkers could distort the orientation
and the charge-driven bundling of DNA in the NET. Impor-
tantly, inhibition of endogenous polyamine incorporation
and interfering with the cross-linking process lead to
impaired pathogen trapping capacity of the NET through
the disturbance of its natural structure. These results indicate
that endogenously adjusted covalent polyamine conjugation
and cross-linking of NET-specific proteins contribute to the
overall stability of NET and are essential for its biological
function.
Extracellular histones have cytotoxic effect on endothelial
cells and can cause fatal organ dysfunctions through micro-
vascular necrosis.47–49 They act as damage-associated
molecular patterns and trigger innate immune response either
via the NOD-like receptor family, pyrin domain containing
3 (NLRP3) inflammasome or various TLR pathway activations
that also could lead to tissue injury.48,50,51 Furthermore,
extracellular histones induce platelet aggregation and throm-
bus formation.52–54 Recently, neutrophils and NET formation
have been also associated with autoimmune manifestations:
PAD4 catalyzed histone citrullination increases their antigeni-
city and potentially leads to autoimmunity (e.g., rheumatoid
arthritis, Felty’s syndrome).55,56 Normally, DNA content of the
induced NET is rapidly degraded by DNAases and scavenged
from the circulation by professional cells. Compromised
clearance and persistent exposure of DNA together with the
associated histones in susceptible individuals enforces auto-
antigen presentation and leads to expansion of autoreactive
lymphocyte clones and consequent autoantibody production
as exemplified in lupus.57–59 Based on our findings, we also
propose that in analogy to protein cross-link formation in
apoptosis60,61 NET-specific cross-links could prevent
spreading of neutrophil intracellular contents and limit harmful
release of proteins (histones, NE, MPO) as well as genomic
DNA into the circulation. Localizing cytotoxic and immunos-
timulatory components of the NET to the site of the infection by
regulated protein cross-linking – with the help of MPO-
dependent formation of chlorinated polyamines and TGase
activation – may significantly contribute to prevention of
harmful consequences of the host response to invading
microbes executed by NETosis.
Materials and Methods
Isolation of human peripheral neutrophils. For these studies, approval
was obtained from the ethics committee of the Medical and Health Science Center,
University of Debrecen, Debrecen, Hungary (DEOEC RKEB/IKEB Prot. No. 2745-
2008). From healthy individuals, 50 ml of venous blood was collected into vacutainer
tubes containing EDTA (BD Biosciences, San Jose, CA USA, 367525) and
centrifuged 15 min, 2500 r.p.m at RT to remove plasma containing platelets. Cells
(∼25 ml) were transferred into a 50 ml tube and 12 ml dextrane (Pharmacosmos
A/S, Holbaek, Denmark, Dextran T500) (3% dextrane in saline solution) was given
to the cells. The tube was filled up to 50 ml with saline solution and incubated for
30 min at RT. Supernatant containing white blood cells was collected and diluted 4x
with phosphate-buffered saline (PBS)-EDTA (20 mM), then cells were centrifuged
(1800 r.p.m., 7 min, 4 °C). The pellet was suspended in 3 ml PBS-EDTA and the
cells were layered on a Histopaque (Sigma-Aldrich, St. Louis, MO, USA, 11191 and
H8889) gradient (6 ml Hp 1119, 5 ml Hp 1077 in a 15 ml tube) and then centrifuged
for 30 min, 1800 r.p.m. at 4 °C. The supernatant (containing lymphocytes and
monocytes) was discarded; neutrophils were collected and washed 2x with 50 ml
PBS-EDTA (20 mM) to remove the rest of the platelets.
Induction of NET formation and amine treatment. Isolated human
neutrophils were seeded in 6-, 12-, 24- or 96-well tissue culture plate to a density of
2.0 × 106/ml medium (RPMI 1640) (Sigma, R5886) and activated with 20 nM PMA
(Sigma, P8139) or with S. aureus (1 : 10 neutrophil:bacterium ratio) for 4 h at 37 °C
in a 5% CO2 atmosphere. Mono- and polyamine treatment were carried out as
follows: SPM (Sigma, S3256) 2 mM; methylamine (Sigma, 426466) 2 mM; PNH2
(Sigma, 171409) 2 mM; MPNH2 (Sigma, 496138) 2 mM, BPNH2 (Zedira, B002)
2 mM for 4 h.
Detection of NET with laser scanning confocal microscopy.
Neutrophils were seeded in eight-well coverslip chambers at 5 × 105 cell/200 μl per
well density with or without induction of NET formation induced by PMA (20 nM,
4 h). After 4 h, cells were fixed with 4% paraformaldehyde (Sigma, P6148) in PBS
(10 min, RT) and DNA content of the cells and NET was stained either with SYTO
83 Orange or SYTO green fluorescent nucleic acid stain (Invitrogen/Thermo Fisher
Scientific, Waltham, MA, USA, S11364, S34854).
Purification of NET proteins. Human neutrophils were seeded in six-well
tissue culture plates to a density of 2.0 × 106/ml in 4 ml medium/well (RPMI 1640)
and activated with 20 nM PMA for 4 h at 37 °C in a 5% CO2 atmosphere. Each well
was carefully washed after removing the supernatant by pipetting 1 ml of pre-
warmed protease inhibitor cocktail (Sigma-Aldrich, P8340) containing RPMI into the
well along the wall of the well and incubated for 5 min at 37 °C. Subsequently, the
NETs were digested for 20 min in 1 ml RPMI with 10 U/ml DNase-1 (Worthington,
Biochemical Corp., Lakewood, NJ, USA, LS006333). Supernatants were collected
on ice and the samples were centrifuged at 16 000 × g at 4 °C to remove debris. In
all, 0.5 ml of supernatant was mixed with 1.5 ml of ice-cold acetone (−20 °C) in a
2 ml Eppendorf tube and incubated overnight at − 20 °C to precipitate protein
content. Samples were centrifuged at 10 000 × g for 30 min at 4 °C then matched
protein pellets were solubilized in 200 μl Laemmli buffer+50 μl 5x-SDS loading
buffer, denatured at 100 °C for 10 min and used for further analysis.
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Quantification of polyamines incorporated into proteins with
ELISA. In all, 100 μl of neutrophil cell lysate (1–5 μg/μl protein in Laemmli buffer)
was incubated in 96-well ELISA plate (maxisorb Nunc plate) for 2 h at RT to bind
neutrophil proteins onto the plate surface. Wells were washed with 200 μl
PBS/Tween (0.1%) and blocked by incubating with 200 μl PBS/Tween (0.1%)
supplemented with 5% bovine serum albumin (BSA) and 5% goat serum (Sigma-
Aldrich, G9023) for 1 h at RT. After washing the wells with 200 μl PBS/Tween
(0.1%), 100 μl of rabbit anti-SPM antibody (Covalab, S.A.S., Villeurbanne, France,
pab0022) or rabbit serum (Covalab) as negative control was given to the wells in
1 : 100 dilution in PBS/Tween (0.1%) supplemented with 5% BSA and 5% goat
serum for 2 h at RT. Wells were washed 3x with 200 μl PBS/Tween (0.1%) and
followed by secondary antibody (horseradish peroxidase (HRP)-conjugated anti-
rabbit antibody) (Covalab, lab0273) in 1 : 1000 dilution in 100 μl PBS/Tween (0.1%)
for 1 h at RT. Wells were washed 3x with 200 μl PBS/Tween (0.1%) and
incorporated polyamines were detected using 100 μl substrate solution (3,3',5,5'-
tetramethylbenzidine ready-to-use substrate solution, Sigma, T4444) for 5–10 min at
RT. Reaction was determined by adding 50 μl 2 N sulfuric acid and optical density
was measured at 450 nm by an ELISA reader.
Protein purification and western blot. Resting and NETosing neutrophils
were collected, washed with cold PBS-EDTA (20 mM) and lysed in cell lysis buffer
(10 mM Tris, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1% Triton X-100, 10% glycerol,
0.1% SDS). Cell lysates were denaturated in a buffer containing 0.125 M Tris-HCl,
pH 6.8, containing 4% SDS, 20% glycerol, 10% mercaptoethanol and 0.02%
bromophenol blue at 100 °C for 10 min. In all, 20 μg protein from each sample were
electrophoresed in 10% SDS-polyacrylamide gels and electroblotted onto PVDF
membranes. The blots were first saturated with 5% BSA in Tween 20-tris-buffered
saline (TTBS). Then, mouse monoclonal antibody against either TG2 (Thermo
Fisher Scientific, Waltham, MA, USA, MS-224-P) or rabbit polyclonal antibody
against TG1 (Zedira, Darmstadt, Germany, A018), diluted in 0.5% BSA in TTBS
1 : 5000 or 1 : 1000, respectively, was added and incubated at 4 °C overnight,
followed by incubation with HRP-labeled affinity-purified goat anti-mouse IgG
(Covalab, lab0252) or anti-rabbit IgG (Covalab) in TTBS 1 : 5000 at room
temperature for 1 h. Each step was followed by 3 × 15-min washes in TTBS. FXIII-A
was visualized by ECL Kit (Advansta, Menlo Park, CA, USA, K-12045-D50).
Immunofluorescent staining. Neutrophils were seeded in eight-well
coverslip chambers at 5 × 105 cell/200 μl per well density with or without induction
of NET formation induced by PMA (20 nM, 4 h) or S. aureus (1 : 10 ratio, 4 h). After
4 h, cells were fixed with 4% paraformaldehyde (Sigma, P6148) in PBS (10 min,
RT), and then permeabilized with 0.1% Triton X-100 (Sigma, X100) in PBS (20 min)
and blocked with TTBS, 5% BSA for 20 min. Cells were incubated with TTBS 1%
BSA containing either mouse monoclonal antibody against TG2 (Thermo Scientific)
or rabbit polyclonal antibody against TG1 (Zedira) and FXIII-A (Zedira, A016) for 2 h
RT; washed three times for 5 min in TTBS-Tween-20 (0.1%). Alexa Fluor-647-
conjugated goat anti-mouse or anti-rabbit secondary antibody (Life Technologies,
A-21235, A-20991) were used for 1 h at room temperature to visualize TG1, TG2
and FXIII-A. To detect protein-bound SPD and SPM in cells and NET structure,
rabbit anti-SPM antibody (Covalab, pab0022) or rabbit serum (Covalab) as negative
control was used in 1 : 50 dilution in TTBS 5% BSA and 5% goat serum (Sigma-
Aldrich) for 8 h at 4 °C followed by the incubation of Alexa Fluor-647-conjugated
goat anti-rabbit secondary antibody (Life Technologies, A-20991) for 1 h at RT.
Protein-bound BPNH2 were detected using Alexa Fluor-647-conjugated streptavidin
(Life Technologies, S32357). DNA content of the cells and NET was stained as
described in Detection of NET with laser scanning confocal microscopy.
Detection of monoamine incorporation to proteins by western
blot. NET formation of seeded neutrophils was induced either in the presence of
2 mM BPNH2 (Zedira, B002) or 100 μM MDC (Sigma, 30432). In order to test the
role of calcium ion in the incorporation of the TGase substrate (BPNH2), NET
formation was induced for 2 h followed by administration of EDTA (1 mM) for 30 min
in order to chelate Ca2+ ions and finally BPNH2 was added for an additional
3 h. After incubation, cells were harvested, protein extracts were generated and
electrophoresed as described in Protein purification and western blot section.
Protein-bound BPNH2 was detected using HRP-labeled streptavidin (Pierce/Thermo
Fisher Scientific, 21130) after electroblotting.
Measurement of protein concentrations. Total protein concentration
of NET samples was determined with Bradford (Sigma) method.62 The BSA (Sigma)
was used as a standard in the protein assay.
SDS-polyacrilamide gel electrophoresis. In all, 20 μg of NET protein
was separated on 12% polyacrylamide gel in a Mini Protean Tetra Cell (Bio-Rad,
Hercules, CA, USA). Electrophoresis was performed for 1.5 h at 30 mA constant
current and ProSieve Protein Ladder (Lonza, Basel, Switzerland) was used as a
protein molecular weight marker. Protein staining was performed using PageBlue
Protein Staining Solution (Thermo Scientific), gels were scanned by Pharos FX Plus
Molecular Imager (Bio-Rad) and the image analysis was done using QuantityOne
Software (Bio-Rad).
In-gel digestion. Protein bands excised from gels were cut into smaller pieces
and dried in speed-vac. Gel pieces were destained using 25 mM ammonium
bicarbonate pH 8.5:50% acetonitrile (ACN) (1 : 1) solution, followed by reduction
with 20 mM dithiothreitol (Bio-Rad) for 1 h at 56 °C. The alkylation was done using
55 mM iodoacetamide (IAA) (Bio-Rad) for 45 min at room temperature in the dark
and the digestion was carried out overnight at 37 °C using 100 ng stabilized MS
grade trypsin (ABSciex, LLC, Framingham, MA, USA). The reaction was stopped by
adding formic acid (FA) (VWR, Radnor, PA, USA) and the tryptic peptides were
extracted from the gel pieces, concentrated and re-dissolved in 10 μl 1% FA and
used for mass spectrometry-based protein identification.
Protein identification by mass spectrometry. The digested samples
were analyzed by reversed-phase liquid chromatography coupled to nanospray
tandem mass spectrometry (LC-MS/MS) using a 4000 QTRAP (ABSciex) mass
spectrometer operated by Analyst software 1.4.2 (ABSciex). The chromatographic
separation was performed on a Proxeon EASY-nLC II (Bruker, Billerica, MA, USA)
at a flow rate of 300 nl/min during a 90-min gradient. The mobile phase A was 0.1%
FA in LC-MS grade water (Sigma), whereas the mobile phase B was ACN with 0.1%
FA. The peptide mixture was first loaded to a 5 × 0.3 mm desalting column packed
with 5 μm C18 resin (Zorbax 300SB, Agilent, Santa Clara, CA, USA), followed by
separation on a 150 mm× 75 μm analytical column (3.5 μm pore size C18 resin,
Zorbax 300SB, Agilent). The nano-flow system was connected to NanoSpray II
MicroIon source, the spray voltage was 2800 V, ion source gas was 50 psi, the
curtain gas was 20 psi and the source temperature was 70 °C.
The 4000 QTRAP mass spectrometer was operated in positive mode and
information-dependent acquisition was administrated. After the first mass scan (300–
1700 amu), the charge of the precursor ion was established using Enhanced
Resolution (ER) scan, then the MS/MS spectra of the two most intensive ions (mass
range 100–1900 amu) were recorded. Two MS/MS spectra were summed in each
case and used for protein identification. For protein identification, ProteinPilot
4.5 software (ABSciex) was administrated using the Paragon algorithm and the
UniProtKB/Swiss-Prot database (2014. 06. 11. version, 545 536 entry). Peptide
sequences having at least 95% confidence were accepted and for protein
identification at least two peptides were used.
MS/MS-based investigation of cross-linked NET proteins by
StavroX software. StavroX 3.2.10 software was used to identify the possible
cross-links among the NET proteins. For the analyzes, MS/MS data were loaded as
Mascot generic format (mgf) files including each recorded spectrum. Amino-acid
sequences of previously identified NET proteins were imported from UniProtKB in
FASTA format. Enzymatic cleavage sites of trypsin were determined as C-terminal
to lysine (Lys) and arginine (Arg) and blocked by proline (Pro). Variable modifi-
cations were defined such as oxidation of methionine (Met) and carbamidomethyla-
tion of cysteine (Cys). SPM, SPD and PUT were used as probable crosslinkers,
searching for the presence of the following cross-links: (1) SPM, SPD and PUT
chloramines are formed upon MPO activity. The chloramines react with protein-
bound lysines forming Lys-polyamine-Lys cross-links (mass change: 200.2, 143.14
and 86.08 Da, respectively). (2) The chloramines react with protein-bound lysines or
methionines forming Lys-polyamine-Met cross-links (mass change: 200.2, 143.14
and 86.08 Da, respectively). (3) SPM, SPD and PUT form cross-links between
protein-bound glutamines (Gln-polyamine-Gln) in a reaction catalyzed by the TGase
(mass change: 166.19, 109.14 and 54.09 Da, respectively). TGase catalyzes the
formation of isopeptide bonds between protein-bound lysines and glutamines, so
the presence of Gln-Lys cross-links (mass change: 17.03 Da) was also checked.
The calculated mass changes were implemented into the software and the MS/MS
spectra were searched for b- and y- ions corresponding to each possible
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cross-links. The results were manually investigated and those hits were accepted
where the score value of the identified cross-linked proteins was positive and the b-
or y- ion series contained at least four ions. The sequence of the cross-linked
peptides and the position of the cross-link was exported to Excel files and used for
the visualization of the network of cross-linked NET proteins.
TG1-specific activity assay. Specific TG1 enzyme activity was evaluated in
neutrophil and HaCaT cell lysate (provided by Dr. Máté Demény, University of
Debrecen) alone or in the presence of 1 mM nonspecific irreversible TGase inhibitor
IAA63 (Sigma, I6125) or 10 μM specific irreversible TG2 and FXIII-A inhibitor
(ZDON) (Zedira, Z006) using the TG1-CovTest (Covalab), which utilize immobilized
SPM as second substrate of TG and the biotin-YEQHKLPSSWPF peptide (pepK5)
as preferred first substrate for TG1, respectively. The assay was performed following
the manufacturer’s instructions. In brief, 50 μl of the reaction buffer was mixed with
50 μl samples and incubated in the microtiter plates at 37 °C for 30 min, and at the
end of this period, wells were emptied and washed three times with 0.1M Tris-HCl,
pH 8.5 containing 0.1% Tween 20. The incorporated biotinylated peptides were
detected using streptavidin peroxidase (R&D Systems, Inc., Minneapolis, MN, USA)
and the peroxidase substrate 3,3′,5,5′-tetramethylbenzidine (Sigma). The reaction
was stopped by the addition of 2 N H2SO4 and the absorbance read on a microplate
reader at 450 nm.
Bacterial trapping assay. Neutrophils were seeded in 96-well culture plate
(0.5 × 106 cells/200 μl per well) in pure RPMI medium and treated with cytochalasin D
(10 μg/ml) (Sigma, C8273) to prevent phagocytosis, PMA (20 nM) and MDC
(100, 250 μM) or BPNH2 (0.5, 2 mM) or left untreated. Plate was centrifuged at
800 g for 10 min and incubated for 3 h at 37 °C to induce NET formation. FITC-
labeled S. aureus was given to cells in 10 μl RPMI in 1 : 100 cell:bacterium ratio
(0.5 × 108 bacterium per well) and incubated for 1 h at 37 °C. Plate was gently
washed three times with 200 μl cold PBS to remove untrapped bacteria and
fluorescence was measured by a fluorescence plate reader (excitation 485 nm,
emission 528 nm). For confocal microscopic analysis, neutrophils were seeded in
eight-well coverslip chambers and treated similarly. After washing untrapped bacteria
away, cells were fixed with 4% paraformaldehyde and DNA was stained with SYTO 83
orange fluorescent nucleic acid stain (Invitrogen, S11364).
Detection of ROS. NADPH oxidase-derived superoxide (O2− ) and other
ROS productions of neutrophils were determined by a L-012-based chemilumines-
cence assay using BioT Synergy H1 microplate reader (Winooski, VT, USA).
Measurements were performed in Cornin Costar 96-Well White Solid Plates in
which the reaction volume of 100 μl contained 5 × 104 cells and 100 μM L-012.
Neutrophils were stimulated with PMA (50 nM) in the presence of different mono- or
polyamines (methylamine, MNH2; PNH2; MPNH2 and SPM) and the chemilumines-
cence was monitored from 2.5 min for 90 min.
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